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Introduction of a transgenic c// TCR (Vo2, V]/8.1) specific for lymphocytic
choriomeningitis virus (LCMV), in the context of H-2D
b into the genome of C57BL/6
mice, has many effects on the development and selection of T cells in both the thymus
and the periphery. These mice produce increased numbers of CD4-8 mature T cells, all
of which express the transgenic TCR, and small numbers of CD4/8 cells using
endogenous TCRs are also produced. This study follows the intrathymic development
of T cells in these TCR o]/transgenic mice, in particular the earliest CD4-8- stages. As
expected, the transgenic TCR is expressed on the cell surface at an earlier developmental
stage than endogenous TCRs in nontransgenic littermate controls. Of the three major
subsets expressing the heat-stable antigen (HSA), only the most mature, the
CD25-CD44- expresses the transgenic TCR, and the earlier CD25-CD44 and
CD25/CD44 do not. Furthermore, in contrast to other TCR o]/transgenic lines, TCR
lineage cells appear to develop normally.
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INTRODUCTION
The development of mature T lymphocytes is a
complex process, involving proliferation and dif-
ferentiation of immature precursor cells through
a series of quite well-defined stages. CD4-CD8-
prothymocytes (originating in the fetal liver or
bone marrow) colonize the thymus and sub-
sequently proliferate and differentiate to give
rise to CD4/8
/ intermediates and ultimately func-
tional cells expressing either CD4 or CD8
(Fowlkes et al., 1985; MacDonald et al., 1988b;
Scollay et al., 1988). During this process, the
T-cell receptor (TCR) c/ and ,3 genes are
rearranged and expressed, and various other
phenotypic markers are acquired or lost (Fowlkes
and Pardoll, 1989; Pearse et al., 1989). Positive
and negative selection events limit the repertoire
of expressed TCR c]/genes to avoid autoreactiv-
ity and account for MHC-restricted antigen rec-
ognition (Kappler and Marrack, 1987; von
Boehmer, 1990). This latter selection phenom-
enon has come under closer scrutiny due to the
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recent availability of transgenic mice expressing
TCR c]/with defined antigen and MHC speci-
ficity (Sha et al., 1988; Teh et al., 1988; Berg et al.,
1989; Kaye et al., 1989; Pircher et al., 1989a). In
the present study, we have analyzed immature
CD4-CD8- T cell subsets that would normally not
express surface TCR from TCR o]/ transgenic
mice in order to assess the effects of premature
TCR expression on early T-cell development.
RESULTS
Increase of Immature (CD4-8-) Thymocytes in
TCR Transgenic Mice
We have previously described transgenic mice
expressing a TCR (V]/8.1, Vo2) that is specific for
LCMV in the context of H-2D
b (Pircher et al.,
1989a). On the selective MHC background (H-2D),
CD8
/ T cells bearing the transgene are positively
selected (Pircher et al., 1989a; Ohashi et al., 1990).
As shown in Fig. 1 and Table 1, such transgenic
thymi are smaller than littermate controls in
adult (8-12 wk) H-2
b mice; however, the imma-
8586 A. WILSON et al.
FIGURE 1. Comparison of the
expression of CD4 and CD8 on
adult thymocytes of H-2 TCR
transgenic mice and their
nontransgene-bearing littermate
controls. Cells were stained with
anti-CD4 PE and anti-CD8 FITC
(both direct conjugates) and, after
live gating by forward light scatter
(FLS) and 90
exclude dead cells and debris,
25,000 cells were analyzed with the
FACScan flow cytometer. Quadrant
gates.were set as indicated using the
negative control (unstained) cells,
and the numbers shown correspond
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ture CD4-CD8- subset is increased both in per-
centage and in absolute numbers in the trans-
genics. On the H=2
d background, where there is
no positive selection of the transgene-bearing
cells, the thymi are of a similar size to their lit-
termate controls, but still have increased num-
bers and percentage of the CD4-CD8- subset
(Table 1).
Expression of Transgenic TCR on CD4-CD8-
Thymocytes
The transgenic TCR expressed in these mice can
be detected by mAbs directed against V]/8.1 (KJ16)
or Ve2 (B20.1). As shown in Fig. 2, a large pro-
portion of CD4-8- thymocytes expressed both the
transgenic TCR c and chains. Furthermore,
staining with mAbs directed against CD3 or TCR
c]/gave similar patterns as V8.1 or V2 staining,
indicating that few (if any) nontransgenic TCR c
fl were expressed. The same staining patterns
were observed on CD4-8- thymocytes in the pres-
ence (H-2b), or absence (H-2d) of the selecting
element, indicating that this has no effect on the
expression of the transgenic TCR.
Subsets of CD4-8-Thymocytes in TCR
Transgenic Mice
CD4-8- thymocytes can be subdivided into sub-
sets on the basis of expression of various surface
markers. Among the most useful markers are
heat-stable antigens (HSA), IL-2 receptor cz chain
(CD25), and Pgp-1 (CD44), which together define
four major subsets (MacDonald et al., 1988b;
Scollay et al., 1988). According to current views
(Pearse et al., 1989; Petrie et al., 1990),
HSA+CD25-CD44
/ immature precursors give rise
sequentially to HSA/CD25+CD44 and sub-
sequently HSA+CD25-CD44 subsets, the latter
being immediate precursors of CD4/8
/ cells
(Wilson et al., 1989; Petrie et al., 1990). The fourth
subset (HSA-CD25-CD44/) is believed not to
belong to the normal generative lineage and may
result from an aberrant selection process (Crispe
et al., 1987; Scollay et al., 1988).
TABLE
Thymus Subsets in TCR ot]} Transgenic Mice
Mice Total CD4/CD8 CD4-CD8 CD4+CD8 CD4-CD8-
thymus
H-2 Littermate 170+28 12+3 7+3 144+27 4+
H-2 Transgenic 92+23 4+1 13+4 71+10 7+2
H-2 Littermate 163+21 16+1 6+1 137+22 3+1
H=2 Transgenic 186+60 20+6 6+1 153+52 6+2
Data expressed absolute number of cells per thymus (xl0-r’)+SD, and the of four (H=2d) and nine (H-2b) experiments each using pools of two to eight mice.IMMATURE THYMOCYTES IN TCR TRANSGENICS 87
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FIGURE 2. Expression of the TCR
on immature (CD4-CD8-)
thymocytes from H-2 o/J
transgenic mice and their littermate
controls. Single-parameter profiles
of surface TCR expression on
purified CD4-CD8- thymocytes
were obtained by staining with
culture supernatants followed by
goat antirat FITC for the CD3
(17A2), Vow2 (B20.1), and V]/8 (KJ16);
and with biotin conjugates followed
by PE-streptavidin for oJ (H57) and
.?’8 (GL3). Solid lines correspond to
transgenic and dotted lines to the
littermate controls. Negative
controls (second stages alone) have
been omitted from this plot to
simplify it, but were the same as the
negative peaks for the littermate
control.
Comparison of these major CD4-8- subsets in
adult H-2
b TCR transgenic mice and littermate
controls (Table 2, Fig. 3) revealed no significant
differences in the two putatively most immature
populations (HSA/CD25-CD44+ and
HSA+CD25/CD44-). In contrast, the putatively
most mature (HSA/CD25-CD44-) CD4-8- subset
was substantially increased in absolute numbers
in the transgenics, and the "aberrant"
(HSA-CD25-CD44/) subset was much reduced.
Similar results were obtained from transgenic
mice on the H-2
d background.
Expression of Transgenic TCR on CD4-8-
Subsets
The CD4-8- subsets described before were ana-
lyzed for expression of the transgenic TCR.
Transgenic TCR (Vfl8.1 or Vow2) was found on the
relatively mature HSA/CD25-CD44 subpopu-
lation and was not detected on the less mature
+ + + HSA CD25-CD44 and HSA CD25 CD44-subsets
(Fig. 4, and data not shown). The HSA- subset
could not be analyzed f-or TCR expression in the
transgenics due to the small number of cells pre-
sent; however, this subset was readily detectable
in the control littermates, where many cells
expressed V]/8.2 (data not shown; Budd et al.,
1987; Fowlkes et al., 1987).
Expression of TCR ?’c in TCR o]/Transgenics
Several studies have suggested that expression of
TCR ]/ transgenes leads to allelic exclusion of
endogenous TCR ’
genes as well as TCR ]/
(Fenton et al., 1988; Uematsu et al., 1988; von
Boehmer et al., 1988; Pircher et al., 1990). As
shown in Fig. 5 and Table 3, TCR ,c + cells were
readily detectable in the CD4-8- subset of the H-
2
b or H-2
d TCR o]/transgenics described here.
Although the relative percentage of TCR ,+
cells was lower in transgenics than in littermate
controls, the absolute number was not signifi-
cantly different between the two groups (Table
TABLE 2
Immature (CD4-CD8-) Thymus Subsets in TCR o]/Transgenic Mice
HSA CD25-CD44- HSA-CD25-CD44 Mice HSA/CD25-CD44 HSA/CD25+CD44
H-2 Littermate 0.19+0.03 2.59+0.65 1.27+0.11 0.43+0.24
H-2 Transgenic 0.21+0.05 2.87+0.92 3.89+0.07 0.17+0.08
H-2 Littermate 0.37* 0.96+0.08 0.68+0.29 1.11+0.37
H-2 Transgenic 0.32* 0.95+0.33 4.76+0.25 0.36+0.19
aData expressed absolute number of cells per thymus (x1076), +SD* only value obtained. Results the of three (H-2d) and six (H-2b) experiments each using
pools of four to twelve mice.88 A. WILSON et al.
3), thus suggesting that the TCR 7/ lineage
develops normally in these TCR o]/ transgenic
mice.
by FLS) among CD4-8- transgenic thymocytes
(data not shown).
Other Phenotypic Markers on TCR Transgenic
CD4-8- Thymocytes
We also compared the expression of other surface
markers on H-2
b TCR transgenic versus control
CD4-8- thymocytes (Fig. 6). Several markers that
are normally associated with the degree Of T-cell
maturation (such as CD5 and Mel-14) were
expressed at higher levels on the transgenic
population. On the other hand, a marker associ-
ated with cell division (RL73).was expressed at
reduced levels on transgenic versus control
CD4-8- cells. This latter result was confirmed by
a reduced frequency of large blast cells (assessed
Analysis of "Immature" CD4-8
/ Thymocytes in
TCR Transgenic Mice
In normal mice, differentiation of CD4-8- to
CD4/8
/ thymocytes frequently occurs via a rap-
idly cycling CD4-8
/ blast intermediate that
expresses high levels of HSA and no detectable
CD3 (MacDonald et al., 1988a; Shortman et al.,
1988). As shown in Fig. 7, all CD4-8
/ thymocytes
in H-2
b TCR transgenic mice expressed high
levels of CD3 (as .expected), and low levels of
HSA as compared to control littermates. Further-
more, few blast cells were detectable (by FLS
analysis) in the transgenic CD4-8+ population
(Fig. 7). By these criteria, "immature" CD4-8
FIGURE 3. Immature thymus
subsets defined by the surface
expression of HSA, CD25, and
CD44. CD4-CD8- thymocytes from
H-2 transgenic and littermate
control mice stained in the top panel
with anti-CD44 (PgP1) culture
supernatant and goat antirat Ig
FITC second stage, followed by rat
Ig to block any free binding sites,
then anti-HSA biotin conjugate
followed by PE-streptavidin; and in
the second panel with anti-HSA
FITC and anti-CD25 PE, both direct
conjugates. Live gating to exclude
dead cells and debris was
performed, quadrants were set
using second stage alone or
unstained cells respectively’, and












FIGURE 4. Expression of V or Vfl8 on subsets of H-2
CD4-CDS- thymocytes. Purified CD4-CDS- thymocytes were
stained in three colors as follows: culture supernatants for the
anti-TCR antibodies, second-stage fluorescein conjugates, and
rat Ig for blocking were as described in Figs. 2 and 3; this was
followed by anti-CD25-PE (direct conjugate), anti-HSA-biotin
and finally TR-PE-avidin. Cells were analyzed and live gating
performed as described in Fig. 1, except that 100,000 events
were collected. The HSA+CD25 and HSA/CD25 were selected
by a second gating and the TCR expression on these
subpopulations obtained. Solid lines and shading correspond
to transgenic and dotted lines to littermate controls.
CD25 +
thymocytes are lacking in the TCR transgenic
thymus. However, CD4-8
/ cells with a lower
level of CD8 are found in the transgenic thymi in
numbers comparableo that of the littermate con-
trols (1.5+0.4% and 1.6+0.6%, respectively; see
Fig. 1). As noted elsewhere, this phenotype may
correspond to relative immaturity of these cells
(Shortman et al., 1988). The recently described
CD4/8-3 "immature" thymocyte showing a simi-
lar phenotype and morphology (Shortman et al.,
1988; Matsumoto et al., 1989; Hugo et al., 1990)
was also virtually undetectable in these trans-
genic mice.
DISCUSSION
It is well established that the precursors of
mature T lymphocytes are contained within the
CD4-8- thymocyte subset (Fowlkes et al., 1985;
Crispe et al., 1987; Shimonkevitz et al., 1987;
Scollay et al., 1988). The d.evelopmental sequence
occurring within that population is now more
clearly understood (Pearse .et al., 1989; Petrie et
al., 1990), although the precise events that direct
this differentiation are not. In this communi-
cation, we have analyzed CD4-8- thymocytes
from mice expressing a transgenic TCR c]/ in
order to gain further insights into early T-cell
development. In normal mice, TCR c]/ is first
expressed at the CD4/8+ stage of thymus devel-
opment and hence TCR expression in transgenic
mice allows cross-correlations with other pheno-
typic markers believed to define early develop-
mental stages.
The current consensus view of lineage relation-
ships among major CD4-8- subsets (Fowlkes and
Pardoll, 1989; Petrie et al., 1990) holds that
HSA/CD25-CD44
/ early precursors differentiate
thro.ugh a HSA+CD25/CD44 intermediate stage
to become HSA/CD25-CD44 blast cells prior to
acquisition of CD4 and/or CDS. Consistent with
this model, the present results indicate that only
the latter (presumably most mature) CD4-8-
population expresses detectable transgenic TCR,
and the putatively more immature CD4-8- sub-
sets do not. In contrast to our findings, Teh et al.
(1990) have recently reported expression of trans-
genic TCR o]/on essentially all CD4.-8: thymo-
cytes. The reason for this apparent discrepancy is
not clear; however, it should be noted that the
TCR c and TCR ]/transgenic constructs used by
Teh et al. (1990) were large genomic fragments
(Teh et al., 1988; Uematsu et al., 1988), whereas
the TCR constructs used here were TCR c and ]/
cDNA clones coupled to a H-2K promoter and Ig
heavy-chain enhancer (Pircher et al., 1989b). It is
thus possible that these differences in regulatory
elements lead. to differential ontogeny of
expression of the two TCR transgenes in vivo.
Failure to express the transgene on the early
CD4-8-subsets is not due to lack of function of
the H-2K promoter because H-2K
b is expressed at
high levels on all of these subsets (data not
shown).
In contrast to the three major HSA
/ subsets of
CD4-8- thymocytes, HSA-CD4-8- cells appear not
to belong to the generative lineage (Scollay et al.,
1988; Fowlkes and Pardoll, 1989). Furthermore,
this HSA- subset is peculiar in that it appears late
in development and most of the cells express
TCR o]/ with a strong preference for the V]/8.
variable domain (Budd et al., 1987; Fowlkes et al.,
1987). Interestingly, HSA-CD4-8- thymocytes
were dramatically reduced in our TCR o]/trans-
genic mice. In contrast, Teh et al. (1990) reported
large numbers of HSA- thymocytes (~20% of90 A. WILSON et al.
FIGURE 5. Prescence of TCR ’b
cells in the H-2 CD4-CD8- thymus
population. Expression of TCR o]/
or TCR y correlated with HSA
expression on CD4-CD8-
thymocytes from transgenic or
littermate controls. Cells were
stained with anti-HSA FITC (direct
conjugate) and anti-TCR o:fl or anti-
TCR ’
biotin conjugates, followed
by PE-Av. Live gating to exclude
dead cells and debris, quadrants to
show the position of the negative
controls, and analyses were






total adult CD4-8- cells) in their TCR ofl trans-
genic mice. In interpreting this dramatic differ-
ence, it is noteworthy that the transgenic TCR ]/
chain of Teh et al. (1990) encodes V8.2, whereas
the ]/chain studied here encodes V8.1. Thus, it
may be that V8.2 expression is essential (even in
thymocytes (von Boehmer, 1990) or by some
other mechanism remains to be determined.
transgenic mice) for the development of the
HSA-CD4-8- subset. Whether this subset arises
via aberrant positive selection of V8.a+CD4+CD8
+
TABLE 3
TCR Expression by CD4-CD8- Thymocytes from TCR o]/
Transgenic Mice
Mice CD3 TCR fl TCR,
H-2 Littermate 6.4+0.9 2.5+0.2 3.8+0.6
H-2 Transgenic 57.4+1.1 55.1+3.3 2.8+0.8
H-2 Littermate 12.1+3.0 11.8+1.8 2.4+0.3
H-2d,, Transgenic 52.1+4.3 54.3+0.5 2.2+0.8
aData expressed absolute number of cells per thymus (xl0-’) +SD, and the








FIGURE 6. Changes in the level of expression of other
phenotypic markers. Single-parameter profiles of various
surface antigens on total CD4-CD8- thymocytes from the H-2
transgenics or their littermate controls. Cells were stained with
culture supernatants, followed by a goat antirat Ig FITC
conjugate. Shaded profiles are from transgenics and the
unshaded from the littermate controls.IMMATURE THYMOCYTES IN TCR TRANSGENICS 91
FLS CD3 HSA
log fluorescence
FIGURE 7. The "immature" CD4-CD8 thymocyte. CD4- thymocytes were isolated from H-2 transgenics or their littermate
controls and stained in three colors with, in the following order, anti-CD3 (17A2 culture supernatant), goat antirat Ig PE, rat Ig for
blocking, anti-HSA FITC, anti-CD8 biotin, and finally TR-PE-Av. Live gating to exclude dead cells and debris was performed as
in Fig. 1, then the CD8 cells were selected by a second live gate on the FL3 (TR-PE-Av/) cells. Single-parameter profiles are
shown for the FLS (reflecting relative cell size), CD3, and HSA expression of the CD4-CD8 thymocytes. Solid lines correspond to
transgenic and dotted lines to littermate controls.
Transition of thymocytes from the CD4-8- to
CD4/8+ compartment may involve an intermedi-
ate CD4-8
/ (MacDonald et al., 1988a; Shortman et
al., 1988) or CD4/8 (Hugo et al., 1990; Matsum-
oto et al., 1989) cell expressing little or no detect-
able surface TCR. In mouse, the "immature
CD8 population is rapidly cycling and exhibits
high levels of HSA. By these criteria, no imma-
ture CD4-8 thymocytes could be detected in TCR
ofl transgenic mice. The absence of this inter-
mediate subset may result from accelerated dif-
ferentiation of the immediate CD4-8- precursors
of these cells. Indeed, HSA/CD25-CD44 thymo-
cytes were present in elevated numbers in TCR
c]/transgenic mice of both the H-2
b (selecting)
and H-2
d (nonselecting) backgrounds. In
addition, this subset expressed enhanced levels
of several phenotypic markers (CD5, Mel-14) and
a decreased proportion of cycling cells, both
traits that are usually associated with T-cell
maturation. Therefore, the premature expression
of surface transgenic TCR, even if it cannot be
positively selected (as on the H-2
d background),
may be associated with accelerated maturation of
immature thymocytes. Furthermore, these data
provide evidence that the "immature," CD4/8-3
or CD4-8/3 subsets are not obligatory stages in
the differentiation from CD4-8- to CD4/8+ cells
(Wilson et al., 1989; Petrie et al., 1990).
Considerable controversy surrounds thedevel-
opmental relationship between TCR o]/and TCR
’
lineages (Fowlkes and Pardoll, 1989). In this
context, several studies have indicated that intro-
duction of a rearranged TCR ]/transgene effec-
tively inhibits further gene rearrangement at the
TCR ’locus, presumably due to some transacting
allelic exclusion mechanism (Fenton et al., 1988;
von Boehmer et al., 1988), and other reports have
suggested that a partial inhibitory effect of trans-
genic TCR ]/on TCR/,.rearrangement occurs, but
that the TCR y population remains unchanged
(Pircher et al., 1990). In other studies using
and/or ’
transgenic mice, complete inhibition
(Bonneville et al., 1989), no effect (Dent et al.,
1990; Ishida et al., 1990), or enhancement (Ferrick
et al., 1989) of the TCR ?’c lineage have been
reported. In the TCR ofl transgenic mice reported
here, TCR?’
+ cells were readily detected in the
CD4-8- thymocyte subset and absolute numbers
of these cells were identical to the values
obtained in control littermates. In addition, the
TCR ’expressing dendritic epidermal T cells
(DETC) isolated from the skin of these TCR
transgenic mice were shown to be indistinguish-
able (both in absolute numbers and V’3 usage)
from those found in their littermate controls (P.
Ohashi et al., unpublished data). Thus, it seems
that TCR o]/and TCR ,c lineages are controlled
independently in these animals; however, it is
possible that TCR , cells develop normally due
to a delayed expression of the TCR o]/transgene
(see before).92 A. WILSON et al.
In conclusion, the premature expression of a
defined TCR c]/ transgene provides a useful
model system in which to test the predicted
developmental lineage of immature (CD4-8-) thy-
mocyte subsets. Furthermore, the comparison of
CD4-8- thymocytes expressing different trans-
genic Vfl domains may ultimately lead to new
insights regarding the developmental origin of
the HSA-CD4-8- subset.
MATERIALS AND METHODS
bit Company, Buxted, UK) and 10 units/mL of
DNase I (Boehringer Mannheim GmbH,
Mannheim, West Germany) to prevent excessive
clumping of dead cells and debris. Dead cells
were removed by centrifugation over Isopaque-
Ficoll (Pharmacia, Uppsala, Sweden). To ensure
purity of the final preparation, this entire pro-
cedure was repeated with the cells at 107/mL.
CD4- thymocytes were prepared in the same
manner with the omission of the anti-CD8 anti-
body. In both cases, the rsultant cells were
greater than 98% pure.
Mice
All the mice used in this study were bred and
maintained at the Swiss Institute for Experimen-
tal Cancer Research (Epalinges, Switzerland).
The transgenic TCR (VOa,JOfTA31/V8.1,D,J2.4,
Cfl2) was derived from a LCMV/H-2Db-specific
cytotoxic T-cell clone P14 (Pircher et al., 1987).
Transgenic males on either a C57BL/6 (H-2b) or
Balb/c (H-2d) genetic background (Pircher et al.,
1989a) were heterozygously bred with normal
MHC compatible 6-8-week-old females. In this
way, a colony of TCR o]/transgenic mice on the
selective (H-2b) or nonselective (H-2d) back-
ground and their nontransgene bearing lit-
termates were established. Litters were screened
for transgene-bearing mice at approximately 4
weeks of age by staining peripheral blood lym-
phocytes with the monoclonal antibody KJ16,
which binds the V/8.1 and V/8. TCRs, followed
by goat antirat Ig-FITC, and then counterstaining
with a mixture of anti-CD8 biotin and either anti-
CD4-PE or anti-CD4 biotin and finally PE-strep-
tavidin. The percent of V]/8-bearing T cells was
15-20% for the nontransgene-bearing littermates
and 85-90% for the transgenics.
Isolation of Immature Thymocytes
CD4-CD8- thymocytes were purified from total
thymus by treating cell suspensions at 5xl07/mL
in DMEM supplemented with glutamine and
Hepes buffer and containing 1% FCS, with pre-
viously determined concentrations of the anti-
CD4 mAb RL1.172.4 (Ceredig et al., 1985) and the
anti-CD8 mAb 3.168.8..1 (Sarmiento et al., 1982)
for 20 min on ice, followed by 45 min at 37C
after the addition of rabbit complement (final
concentration 1/20, supplied by The Buxted Rab-
Monoclonal Antibodies
Culture supernatants were prepared from
hybridomas grown in the laboratory as follows.
Anti-CD3, 17A2 (Miescher et al., 1989/1990);
anti-Vc2, B20.1 (B. Malissen et al., manuscript in
preparation); anti-V-fl8.1,8.2, KJ16.133.18 (Haskins
et al., 1984); anti-CD44 (PgP1), IM7.8.1
(Trowbridge et al., 1982); anti-CD25 (IL2Rc),
PC61.5 (Ceredig et al., 1985); Mel-14 (Gallatin
et al., 1983); anti-CD5, 53-7.3 (Ledbetter and
Herzenberg, 1979); and RLI.73.2 (MacDonald et
al., 1985). Biotin conjugates were prepared in the
laboratory, and were as follows: anti-CD8,
53.6.72 (Ledbetter and Herzenberg, 1979); anti-
CD4, GK1.5 (Dialynas et al., 1983); anti-HSA,
M1/69 (Springer et al., 1978); and anti-CD25 (as
before). Anti-TCR o]/, H57.597 (Kubo et al., 1989)
and anti-TCR//d/,.GL3 (Goodman and Lefrancois,
1989), both biotin conjugates, were the kind gift
of J.-P. Rosat, WHO Immunology Research and
Training Unit, Epalinges, Switzerland. Fluor-
escein (FITC) conjugates of anti-CD8, H35-17.2
(Goldstein et al., 1982) and anti-HSA, M1/69 (as
before) were prepared in the laboratory. Anti-
CD4-PE was purchased from Bectin Dickinson,
Mountain View, CA. Second-stage reagents were
purchased as follows: Goat antirat Ig-FITC (Tago,
Inc., Burlingame, CA), Goat antirat Ig-PE
(Southern Biotechnology Associates, Inc.,
Birmingham, AL), PE-Av (R-phycoerythrin-
streptavidin, from Caltag Laboratories, San Fran-
cisco, CA), and PE-TR-Avidin (R-phycoerythrin
(PE), covalently bound to texas red (TR), and
coupled to avidin; with an excitation wavelength
characteristic of PE and emission wavelength
characteristic of TR; from Southern Biotechnol-
ogy Associates, Birmingham, AL).IMMATURE THYMOCYTES IN TCR TRANSGENICS 93
Staining Procedures
Single two-color and three-color staining of thy-
mocytes was performed as previously described
(Shortman et al., 1988; Wilson et al., 1988, 1989).
Analysis of these stained cells was done with a
FACS II for the single staining and a FACScan for
the two- and three-color fluorescence (both Flow
Cytometers were supplied by Becton Dickinson,
Mountain View, CA).
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